BioSpectrum - The business of biotech

Bio Spectrum is India's first monthly comprehensive Biotech business magazine covers the entire happenings in the exciting areas of BioPharma, BioAgriculture,BioInformatics, BioIndustrial, BioSuppliers and BioServices . BioSpectrum has columns by India's top policy makers, biotechnology professionals, scientists and NGOs and show cases the emerging Indian entrepreneurship in biotechnology.

BioSpectrum Reach – Reaches over 40,000 key decision makers in the Pharma and Biotech industry. Readers of BioSpectrum are from among the key policy makers, Consultants, Fund managers, Key executives and the influencers in pharmaceutical / agricultural companies, research labs / educational institutes, the clinical research, clinical trials and contract manufacturing organizations and the industrial sectors besides other auxiliary sectors.

BioSpectrum: Achievements In our quest to be the leading source of information for the biotechnology business in India;

• B ioSpectrum is already the “ Voice of Indian BT industry ”.
• B ioSpectrum hosted the F irst- Biotech “CEO Summit” on 23 rd September, 2005 in Hyderabad participated by over seventy CEOs, directors, policy makers, heads of research establishments, and venture capitalists on a single platform and debate, discuss, and focus on strategies with the objective of achieving $5 billion by 2010.
• S ecretary, Department of Biotechnology, Government of India and other key policy makers use the magazine as a platform to reach out to the Indian Biotech industry.
• B iotech Industry Annual Awards instituted to honor the champions of this industry.
• First ever survey of BT Industry covering over 300 companies in association with Association of Biotechnology Lead Entrepreneurs (refer June 2005 BioSpectrum issue).

Engaging the Indian Biotech Community

• BioSpectrum has emerged as the most preferred forum to engage the Indian biotech community.
• S uccessful campaigns: National Biotech Policy Draft in progress. Mashelkar, Swaminathan Task Forces on regulatory affairs: Biotech Fund.
• B ioSpectrum works closely with the leading Industry associations, ABLE, AIBA, CII, FICCI and ASSOCHAM and state governments to further the growth and spread of biotechnology.

• B ioSpectrum is widely quoted by E xport- I mport B ank of I ndia report and India Brand Equity Foundation (IBEF) and at all Biotech meetings.
• O nly magazine to have interviews with DBT Chiefs, both Dr MK Bhan and Dr (Mrs) Manju Sharma
• L eading personalities like Dr R A Mashelkar regularly express their views

Contact Information